Fundz

Integra Therapeutics raised €10.7M in funding led by IC Fund and CDTI Innvierte to enhance its gene writing platform and advance CAR-T therapies.

PRIVATESep 08, 2025

Amount Raised

€10.7 Million

Round Type

Funding Round

BarcelonaBiotechnologyHealth CareTherapeutics

Investors

AdBioTakedaAd BioColumbusInvivoIC FundCDTI Innvierte

Description

Integra Therapeutics, based in Barcelona, Spain, secured €10.7M in funding. The backers included IC Fund and CDTI Innvierte, along with existing investors. The funds will be used to incorporate new advances into their gene writing platform and validate CAR-T therapies. Founded in 2020, Integra specializes in gene writing tools for advanced therapies.

Quick answer

Integra Therapeutics raised €10.7 Million in a Funding Round round, dated September 8, 2025. Investors: AdBio, Takeda, Ad Bio, Columbus, Invivo, IC Fund and CDTI Innvierte. Integra Therapeutics is based in Barcelona, Catalonia, Spain.

How much did Integra Therapeutics raise?
Integra Therapeutics raised €10.7 Million in a Funding Round round on September 8, 2025.
Who invested in Integra Therapeutics?
AdBio, Takeda, Ad Bio, Columbus, Invivo, IC Fund and CDTI Innvierte are named as investors in this round.
What does Integra Therapeutics do?
Integra Therapeutics, headquartered in Barcelona, is a biotech company that specializes in creating gene writing tools for advanced therapies.
Where is Integra Therapeutics based and how big is it?
Integra Therapeutics is based in Barcelona, Catalonia, Spain.
Who are the decision-makers at Integra Therapeutics?
Fundz holds 2 contacts at Integra Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Integra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • ENA Respiratory raised $22M (Series B) on October 22, 2025.
  • Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Valink Therapeutics raised $12M (Pre-Series A) on October 20, 2025.
  • Theriva Biologics raised $13M on October 17, 2025.

Who to call at Integra Therapeutics, and when

A new round usually means Integra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Integra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Integra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Integra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Integra Therapeutics

Location

Barcelona, Catalonia, Spain

About

Integra Therapeutics, headquartered in Barcelona, is a biotech company that specializes in creating gene writing tools for advanced therapies. The company was founded in 2020 as a spin-off of the Pompeu Fabra University (UPF) and focuses on resolving the current limitations on gene writing: size, precision, and stability.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Integra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Integra Therapeutics's next move

See what Strategic adds

Integra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.